Company intelligence / Profile preview

AESKU.GROUP

Wendelsheim, Rhineland-Palatinate, Germanyaesku.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Over two decades of experience with more than 620 products available worldwide for the early detection and monitoring of autoimmune diseases; recognized leader in autoimmunity diagnostics with ISO certification and global reach. No clinical trial results as the focus is on IVDs.

Therapeutic areas: CardiovascularImmunology
Modalities: Diagnostic test kit (ELISA)Diagnostic test kit (IFA)Diagnostic test kit (BLOT)Software/automation platform for diagnostics
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on AESKU.GROUP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AESKU.GROUP.

Explore the full profile